CerRx's Seed Round

CerRx raised a round of funding on February 04, 2013.

CerRx is an intermediate stage, targeted anticancer drug discovery and development company. The flagship in the CerRx pipeline is the intravenous (emulsion) fenretinide (4-HPR) formulation (patents is…

Articles about CerRx's Seed Round: